Related Experiment Video
Updated: Jul 13, 2026
08:20
In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
Published on: August 17, 2022
Malaria vaccines in development.
1Clinical Research and Development, GlaxoSmithKline Biologicals, Rixensart, Belgium. ballouw@medlmmune.com
Expert Opinion on Emerging Drugs
|August 9, 2005
Summary
Increased funding accelerates malaria vaccine development, showing promise in trials. Ensuring equitable access for all populations remains a critical challenge for global malaria control.
Area of Science:
- Vaccinology
- Infectious Disease Epidemiology
- Global Health
Background:
- Significant public and private investment is driving rapid advancement in malaria vaccine candidates.
- Recent clinical trials in diverse populations offer crucial data on vaccine efficacy and requirements.
Purpose of the Study:
- To review the current landscape of malaria vaccine development.
- To identify key challenges and strategies for successful malaria vaccine implementation.
Main Methods:
- Analysis of recent clinical trial outcomes.
- Review of funding trends and development approaches.
- Assessment of access and implementation strategies.
Main Results:
- Promising results from early-stage malaria vaccine trials have been observed.
- Candidate vaccines are progressing rapidly through the clinical pipeline.
Conclusions:
- Equitable access to malaria vaccines for populations most in need is a primary hurdle.
- Successful implementation requires innovative strategies, global partnerships, and political commitment.
- Malaria vaccines represent a vital new tool to combat the global burden of malaria.
Related Concept Videos
01:51Vaccinations
Overview
00:58Symbiosis
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...